Patent Assignment
Reel/Frame 048622/0358
Termination and Release of Security Interest in Patents
Recorded: 2019-03-18
Pages: 8
Assignor
ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS ADMINISTRATIVE AGENT
Executed: 2019-03-15
Assignee
APOLLO ENDOSURGERY, INC.
1120 S. CAPITAL OF TEXAS HWY, SUITE 300, AUSTIN, TEXAS, 78746
Covered Properties
(55)
Methods for Early Detection of Heart Disease
Patent:
6,210,976 →
Application:
09/084,069 →
Methods for Detecting Compounds Which Modulate the Activity of an Lpa Receptor
Patent:
6,485,922 →
Application:
09/169,205 →
Enzyme Method for Detecting Lysophospholipids and Phospholipids and for Detecting and Correlating Conditions Associated with Altered Levels of Lysophospholipids
Patent:
6,248,553 →
Application:
09/176,813 →
Disease Conditions by Measuring Lysophosphosphatidic Acid
Patent:
6,255,063 →
Application:
09/314,780 →
Kits for Early Detection of Heart Disease
Patent:
6,534,322 →
Application:
09/489,158 →
Compositions and Methods for Early Detection of Heart Disease
Patent:
6,534,323 →
Application:
09/489,466 →
Method of Detecting Carcinomas
Patent:
6,500,633 →
Application:
09/558,880 →
Determining Existence of Preeclampsia in Pregnancies by Measuring Levels of Glycerophosphatidyl Compounds, Glycerophosphatidycholine, Lysophospholipids and Lysophosphatidylcholine
Patent:
6,461,830 →
Application:
09/585,138 →
Lpa Analogs as Agonists Ofthe EDG2 Lpa Receptor
Patent:
6,380,177 →
Application:
09/602,235 →
Enzyme Method for Detecting Sphingosine-1-Phosphate (Sip)
Patent:
6,448,023 →
Application:
09/661,988 →
Compositions and Methods for the Treatment and Prevention of Cardiovascular Diseases and Disorders, and for Identifying Agents Therapeutic Therefor
Compositions and Methods for the Treatment and Prevention of Cardiovascular Diseases and Disorders, and for Identifying Agents Therapeutic Therefor
Method for Detecting Sphingosine-1-Phosphate (S1P) for Cancer Detection
Compositions and Methods for the Treatment and Prevention of Cancer, Angiogenesis, and Inflammation
Compositions and Methods for the Treatment and Prevention of Hyperproliferative Diseases
Compositions and Methods for the Treatment and Prevention of Cancer, Angiogenesis, and Inflammation
Novel Bioactive Lipid Derivatives, and Methods of Making and Using Same
Methods and Reagents for Detecting Bioactive Lipids
Immune-Derived Moieties Reactive Against Lysophosphatidic Acid
Methods for Decreasing Immune Response and Treating Immune Conditions
Compositions and Methods for Binding Sphingosine-1-Phosphate
Compositions and Methods for Treating Sphingosine-1-Phosphate (S1P) Related Ocular Diseases and Conditions
Compositions and Methods for Binding Lysophosphatidic Acid
Humanized Antibodies and Compositions for Binding Sphingosine-1-Phosphate
Humanized Antibodies and Compositions for Binding Sphingosine-1-Phosphate
Nucleic Acids Coding for Humanized Antibodies for Binding Sphingosine-1-Phosphate
Methods of Using Humanized Antibodies and Compositions for Binding Sphingosine-1-Phosphate
Compositions and Methods for Binding Sphingosine-1-Phosphate
Compositions and Methods for Binding Lysophosphatidic Acid
Pharmaceutical Compositions for Binding Sphingosine-1-Phosphate
Compositions and Methods for Treating Ocular Diseases and Conditions
Use of Anti- Sphingosine-1-Phosphate Antibodies in Combination with Chemotherapeutic Agents
Humanized Antibody Compositions and Methods for Binding Lysophosphatidic Acid
Antibody Design Using Anti-Lipid Antibody Crystal Structures
Methods of Increasing Neuronal Differentiation Using Antibodies to Lysophosphatidic Acid
Application:
12/822,060 →
Publication:
US 2011/0076269
Prevention and Treatment of Pain Using Antibodies to Lysophosphatidic Acid
Application:
12/836,524 →
Publication:
US 2011/0064744
Prevention and Treatment of Pain Using Antibodies to Lysophosphatidic Acid
Prevention and Treatment of Pain Using Monoclonal Antibodies and Antibody Fragments to Lysophosphatidic Acid
Application:
13/183,381 →
Publication:
US 2012/0014946
Prevention and Treatment of Pain Using Antibodies to Sphingosine-1-Phosphate
Methods of Increasing Neuronal Differentiation Using Antibodies to Lysophosphatidic Acid
Application:
13/301,757 →
Publication:
US 2012/0128666
Treatment of Traumatic Brain Injury Using Antibodies to Lysophosphatidic Acid
Application:
13/545,972 →
Publication:
US 2013/0034545
Anti-S1P Antibody Treatment of Patients with Ocular Disease
Methods and Kits for Detecting and Diagnosing Neurotrauma
Application:
13/778,917 →
Publication:
US 2013/0302831
Humanized Antibody Compositions and Methods for Binding Lysophosphatidic Acid
Application:
14/084,593 →
Publication:
US 2014/0199293
Novel Bioactive Lipid Derivatives, and Methods of Making and Using the Same
Application:
14/451,394 →
Publication:
US 2015/0031055
Methods for Binding Cysteinyl Leukotrienes (Cyslts) with Antibodies for Treatment of Disease
Application:
14/523,784 →
Publication:
US 2015/0152172
Prevention and Treatment of Pain Using Antibodies to Sphingosine-1-Phosphate
Application:
14/523,943 →
Publication:
US 2015/0203570
Compositions and Methods for Binding Cysteinyl Leukotrienes (Cyslts) for Treatment of Disease
Application:
14/803,637 →
Publication:
US 2016/0060328
Compositions and Methods for Binding Lysophosphatidic Acid
Application:
14/812,325 →
Publication:
US 2016/0146844
Compositions and Methods for Binding Lysophosphatidic Acid
Application:
14/862,117 →
Publication:
US 2016/0152735
Treatment of Traumatic Brain Injury Using Antibodies to Lysophosphatidic Acid
Application:
14/953,329 →
Publication:
US 2016/0075775
Prevention and Treatment of Pain Using Antibodies to Lysophosphatidic Acid
Application:
15/047,612 →
Publication:
US 2016/0168270
Methods and Kits for Detecting and Diagnosing Neurotrauma
Application:
15/331,880 →
Publication:
US 2017/0254822
Methods of Treating Disease Using Antibodies to Lysophosphatidic Acid
Application:
15/331,881 →
Publication:
US 2017/0114125
Treatment of Neurotrauma Using Antibodies to Lysophosphatidic Acid
Application:
15/331,882 →
Publication:
US 2017/0088634
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Notice of Grant of Security Interest in Patents
Dec 30, 2016
From: APOLLO ENDOSURGERY, INC.
To: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS ADMINISTRATIVE AGENT
Reel/Frame 041224/0766 →
Assignment of Assignor's Interest
Feb 3, 2017
From: SKINNER, MICHAEL K.; JOHNSON, JODI L.; PARROTT, JEFF A.
To: ATAIRGIN TECHNOLOGIES, INC.
Reel/Frame 041170/0859 →
Intellectual Property Security Agreement
Apr 15, 2019
From: APOLLO ENDOSURGERY, INC.
To: SOLAR CAPITAL LTD., AS COLLATERAL AGENT
Reel/Frame 048885/0621 →
Security Interest
Dec 23, 2021
From: APOLLO ENDOSURGERY, INC.; APOLLO ENDOSURGERY US, INC. (F/K/A LPATH, INC.)
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 058980/0199 →
Release of Security Interest
Dec 30, 2021
From: SLR INVESTMENT CORP. (F/K/A SOLAR CAPITAL LTD.)
To: APOLLO ENDOSURGERY US, INC.; APOLLO ENDOSURGERY INTERNATIONAL, LLC; APOLLO ENDOSURGERY, INC.; LPATH THERAPEUTICS INC.
Reel/Frame 058599/0297 →
Termination and Release of Intellectual Property Security Agreement
Apr 5, 2023
From: APOLLO ENDOSURGERY, INC.; APOLLO ENDOSURGERY US, INC.; APOLLO ENDOSURGERY INTERNATIONAL, LLC; LPATH THERAPEUTICS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 063264/0046 →